Format

Send to

Choose Destination
See comment in PubMed Commons below
Hosp Med. 2002 Mar;63(3):162-5.

Somatuline Autogel: an extended release lanreotide formulation.

Author information

1
University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW.

Abstract

Somatuline Autogel provides effective control of growth hormone levels and is at least as effective as intramuscular Somatuline LA. Somatuline Autogel has a first order kinetic profile providing at least 28 days' efficacy with reduced burst release and a more consistent drug release over the dose period. The product is presented in a pre-filled syringe and is given deep subcutaneously.

PMID:
11933820
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center